Related Experiment Video

Updated: Aug 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Effect of lipid modification on progression of coronary calcification

Peter A McCullough1

  • 1Division of Nutrition and Preventive Medicine, William Beaumont Hospital, 4949 Coolidge, Royal Oak, MI 48073, USA. pmc975@yahoo.com

Journal of the American Society of Nephrology : JASN
|October 28, 2005
PubMed

Insights

Lipid modification, particularly lowering LDL cholesterol, can significantly reduce coronary artery calcification (CAC) progression and even cause regression of coronary artery disease (CAD). This approach offers a way to alter the natural course of atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research
  • Lipidology

Background:

  • Coronary artery calcification (CAC) is a marker for coronary atherosclerosis and coronary artery disease (CAD) burden.
  • CAC is associated with traditional CAD risk factors, advanced age, and chronic kidney disease.
  • Lipid profiles, including low HDL, high triglycerides, and high LDL cholesterol, are key drivers of the calcification process.

Purpose of the Study:

  • To review existing data on the impact of lipid modification on coronary artery calcification.
  • To explore the potential of altering the natural history of CAC through lipid-lowering therapies.

Main Methods:

  • Review of studies investigating the effects of lipid-lowering interventions on CAC progression.
  • Analysis of data correlating LDL cholesterol reduction with changes in CAC and atheroma volume.
  • Examination of studies involving statins and sevelamer for their impact on CAC.

Main Results:

  • Annual CAC progression can be reduced from 25-30% to 0-6% with LDL cholesterol reduction.
  • Significant regression of CAC and coronary atheroma volume is suggested at LDL cholesterol levels below 100 mg/dl.
  • Combined LDL reduction and HDL elevation may also reduce carotid intimal medial thickness.

Conclusions:

  • Lipid modification, especially LDL cholesterol reduction, is a viable strategy to slow or reverse CAC progression.
  • Therapeutic interventions targeting lipid profiles can alter the natural course of coronary atherosclerosis.
  • Further research supports the role of lipid management in mitigating the burden of CAD.

More Related Videos

Novel Quantification Protocol for Cardiovascular Calcification Progression Using Longitudinal MicroPET/MicroCT Images08:02

Novel Quantification Protocol for Cardiovascular Calcification Progression Using Longitudinal MicroPET/MicroCT Images

Published on: November 15, 2024

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...